The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Completed
Conditions studied: HIV Infections
In brief
The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....
Key facts
- Study ID
- NCT01034800
- Run by
- National Institute on Drug Abuse (NIDA)
- Starts
- 2006-09-01
- Last updated by the study team
- 2009-12-17
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Institute on Drug Abuse, Biomedical Research Center (BRC) — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.